Embody review

What it is

Embody is operated by Modern Metabolic Medicine, Inc., a Delaware corporation, and trades as Em from joinem.co, with clinical care delivered through the OpenLoop Health licensed-clinician network. Its main Shopify catalogue is entirely compounded semaglutide and tirzepatide, including a compounded oral tirzepatide gum. The peptide and longevity products — sermorelin, NAD⁺, glutathione and MIC+B12 — are not in that catalogue at all; each has its own landing-page funnel on a subdomain. Sermorelin is offered as a growth-hormone therapy, NAD⁺ as 500mg to 1000mg injections. The company states LegitScript certification and names four partner pharmacies: RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx.

How it works

Funnel-first, and it is worth understanding what that means before you enter one. Each peptide has its own landing page with its own promotional banner, its own price and its own claims, separate from the main store, so what you see depends entirely on which advert brought you. The sermorelin page states a free online medical evaluation, prescribing by licensed providers, and — in its own words — no insurance or bloodwork needed. For a growth-hormone-axis peptide that is the sentence to stop on: an IGF-1 baseline is the obvious thing to want before starting a secretagogue, and here its absence is being sold as a feature. The NAD⁺ page includes the telehealth visit and prescription in the price and advertises shipping in one to two days with no membership. The real transparency win is dispensing: four named pharmacies is unusual and checkable. The real caution is behavioural — the company's own record shows a checkout that charges the card before clinical review, a countdown timer applied to an approval window, and a review badge that does not match its own public listing. None of those are illegal; all of them are pressure applied at the moment you are deciding.

Pricing transparency

Both peptide landers advertise a flat rate of $99 a month, and both attach that figure to a summer sale described as saving $100 every month. That is the whole thing to understand here. A flat rate created by a standing discount is a promotional rate, not a price, and Embody's GLP-1 line is where this pattern already has a history: its terms carry a list price materially above the advertised flat rate, and buyers have publicly disputed that the permanent lock was honoured. We have therefore not treated $99 as a floor for this board, and neither should your budgeting. Before ordering, get in writing what the price becomes if the promotion ends, whether the rate is contractually locked or merely marketed as locked, and what dose and quantity the monthly figure supplies — the NAD⁺ page offers a 500mg to 1000mg range, which is a twofold spread with no stated price difference. The company does advertise a six-month satisfaction guarantee and a full refund if you are not approved, though its own terms tie the refund to being disqualified or undispensed rather than to changing your mind.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Embody names four partner pharmacies — RedRock, Health Warehouse, Precision Compounding and Triad Rx — with addresses, which genuinely does let you check who dispenses your medication, and compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are, so that matters. The claims are where this needs contradicting directly. The NAD⁺ lander is headed "start aging backwards", calls NAD⁺ the fountain-of-youth peptide, tells readers it is scientifically proven to help them feel younger, sharper and more alive, and lists revitalising cellular DNA, rejuvenating youthful skin and reducing the risk of aging among its benefits. There are no controlled human outcome trials behind any of that for injected NAD⁺; the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly. The NAD⁺ forms with human data are the oral precursors NR and NMN, and what those trials demonstrate is a raised blood NAD⁺ level — a biomarker, not an outcome. The sermorelin page is more careful, framing benefits as "may support", and its mechanism description is broadly accurate: sermorelin is a GHRH analogue that stimulates the pituitary rather than replacing hormone. But the long-term human outcome data remains thin, and no controlled trial demonstrates the weight, muscle, skin, bone or sleep results the page lists. Glutathione has essentially no controlled human outcome evidence. Individual results vary.

Pros and watch-outs

The evidence behind what Embody prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How Embody compares

A few alternatives worth a look, depending on what you’re optimizing for.

• CoreAge Rx

  Injected or intranasal NAD⁺ at a published price across 50 states

  See CoreAge Rx →
• Live Vital

  Pairing a GLP-1 with a wider peptide and longevity protocol

  See Live Vital →
• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →